BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025

About this update from Biocardia, Inc.

SUNNYVALE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that BioCardia’s CEO, Peter Altman, Ph.D., will participate in a fireside chat at the Alliance Global Partners Virtual Healthcare Company Showcase hosted by Jim Molloy, Managing Director, Equity Research Biotechnology & Specialty Pharmaceuticals at A.G.P., on May 21, 2025. Dr. Altman will share recent business developments on the Company’s therapeutic development pipeline with a focus on its lead CardiAMP autologous cell therapy for the treatment of ischemic heart failure. Fireside Chat Details: Date: Wednesday, May 21, 2025 Time: 03:40 p.m. EDT Speaker : Peter Altman Ph.D., CEO Moderator: Jim Molloy, AGP Managing Director, Equity Research Biotechnology & Specialty Pharmaceuticals Webcast: https://us02web.zoom.us/webinar/register/WN_jB1HgKLvQFmUfC6VBT11mw About BioCardia ® BioCardia, Inc. , headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP ® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms with three cardiac clinical stage product candidates in development. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph ® vascular navigation product platforms. For more information visit www.biocardia.com . CONTACT: MEDIA CONTACT: Miranda Peto, Investor Relations [email protected] (650) 226-0120 INVESTOR CONTACT: David McClung, Chief Financial Officer [email protected] (650) 226-0120

View stock analysis, news, and events for Biocardia, Inc.